Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2008
01/17/2008WO2008008550A2 Compositions and methods for growing human embryonic stem cells
01/17/2008WO2008008360A1 Production of glycoproteins
01/17/2008WO2008008114A2 Use of adipose-derived stem cells for treatment of leukodystrophies
01/17/2008WO2008007755A1 Cell death inducer
01/17/2008WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient
01/17/2008WO2008007581A1 Non-replicating paramyxoviridae virus vector
01/17/2008WO2008007527A1 Method of cultivating cell or tissue
01/17/2008WO2008007525A1 Cell or tissue cultivation apparatus and method of cultivation
01/17/2008WO2008007463A1 Composition for diluting and storing sperm
01/17/2008WO2008007082A2 Cell growth medium
01/17/2008WO2008006927A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same
01/17/2008WO2008006605A2 A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells
01/17/2008WO2008006494A1 Improved process for the culturing of cells
01/17/2008WO2008006458A2 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them
01/17/2008WO2008006430A1 Method for cell preparation of mononuclear cells from bone marrow
01/17/2008WO2008006202A1 Fatty acid desaturases and uses thereof
01/17/2008WO2008006189A1 Mimotope receptors and inhibitors for platelet- platelet and platelet-endothelium interactions
01/17/2008WO2008006168A1 Treatment of excessive neovascularization
01/17/2008WO2007135574A8 Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related method and compositions
01/17/2008WO2007130664A3 Derivation of embryonic stem cells and embryo-derived cells
01/17/2008WO2007119213A3 A culture medium and pharmaceutical composition for regenerating cartilage tissue, a method, uses and products related thereto
01/17/2008WO2007117577A3 High affinity human antibodies to human il-18 receptor
01/17/2008WO2007113591A3 Three dimensional cell culture
01/17/2008WO2007096192A3 Production of biologically active proteins
01/17/2008WO2007084954B1 Selective inhibition of ig20 splice variants to treat cancers
01/17/2008WO2007075812A3 Method of using hepatic progenitors in treating liver dysfunction
01/17/2008WO2007041684A3 Ion flux in biological processes, and methods related thereto
01/17/2008WO2007020655A8 Establishment of a human embryonic stem cell line using mammalian cells
01/17/2008WO2007019119A3 Rna complexes methods of their production and sensors and analytical methods involving same
01/17/2008WO2006095011A8 Engineered human cells
01/17/2008WO2005118786A3 Splice variants of peptide yy, neuropeptide y, pancreatic peptide y and amylin, and uses thereof
01/17/2008WO2003100074A8 Animal genotyping method
01/17/2008WO2003004615A3 Secreted proteins
01/17/2008WO2002066670A3 46798, a human matrix metalloproteinase and uses therefor
01/17/2008US20080016597 Peptide Transporting To Chromoplasts In Petals And Method Of Constructing Plant Having Yellowish Petals By Using The Same
01/17/2008US20080016596 Bacillus thuringiensis Cry gene and protein
01/17/2008US20080016592 transgenic plants; canola, oilseed rape, soybean; host cell; seed; tocopherol biosynthesis pathway
01/17/2008US20080016591 transgenic plant; canola, oilseed rape, soybean; host cell; seed
01/17/2008US20080016590 Soybean cultivar 26170838
01/17/2008US20080016589 Soybean cultivar 5900450
01/17/2008US20080016588 Soybean cultivar 306612412
01/17/2008US20080016587 Soybean cultivar 26660135
01/17/2008US20080016586 Soybean cultivar 306734323
01/17/2008US20080016584 phytases belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed
01/17/2008US20080015790 Automated system and method for harvesting and multi-stage screening of plant embryos
01/17/2008US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof
01/17/2008US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV
01/17/2008US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
01/17/2008US20080015164 Methods and compositions for inactivation of dihydrofolate reductase
01/17/2008US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3
01/17/2008US20080015149 Galectin 11
01/17/2008US20080015147 Method for inhibiting neuronal cell death
01/17/2008US20080015137 Methods and Compositions for Targeting Macromolecules Into the Nucleus
01/17/2008US20080015110 Modified dmo enzyme and methods of its use
01/17/2008US20080014638 Culture medium containing kinase inhibitors, and uses thereof
01/17/2008US20080014637 Process for culturing cells sampled for biopsy
01/17/2008US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker
01/17/2008US20080014635 Methods of increasing protein expression levels
01/17/2008US20080014634 Selective cloning of homoduplex nucleic acids
01/17/2008US20080014633 Manipulation of plant senescence using modified promoters
01/17/2008US20080014624 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs
01/17/2008US20080014609 Methods for Obtaining Thermostable Enzymes, Dna Polymerase I Variants from Thermus Aquaticus Having New Catalytic Activities, Methods for Obtaining the Same, and Applications to the Same
01/17/2008US20080014608 Modified Promoter
01/17/2008US20080014606 Using radiation dosing to remove non-preferred cells from population; purifying one or more cells based on the level of one or more products secreted by the cells
01/17/2008US20080014605 Method and Apparatus for Selectively Targeting Specific Cells Within a cell population
01/17/2008US20080014598 Phospho-specific antibodies to pi3k regulatory subunit and uses thereof
01/17/2008US20080014585 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
01/17/2008US20080014583 Methods for identifying candidate fat-mobilizing agents
01/17/2008US20080014573 Biosample Manipulation Apparatus
01/17/2008US20080014291 Process for the Production of Multi-Component Mineral Substance Preparations
01/17/2008US20080014210 Peptides and antibodies to muc 1 proteins
01/17/2008US20080014206 drug screening for agents potentially useful in the treatment of Mycobacterium tuberculosis infection; drug resistant antibiotics
01/17/2008US20080014203 Immunoglobulin which binds insulin-like growth factor receptor (IGF-IR ) for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents
01/17/2008US20080014197 Neutralizing human anti-igfr antibody
01/17/2008US20080014194 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent and treat parkinson's disease
01/17/2008US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein
01/17/2008US20080014182 Populations of Expanded and Re-Differentiated Adult Islet Beta Cells Capable of Producing Insulin and Methods of Generating Same
01/17/2008US20080014180 Hemangio-colony forming cells
01/17/2008US20080014178 Method for Stimulating Mammalian Cells and Mammalian Cell
01/17/2008US20080014177 Devices, methods, and systems for accessing native neurons through artificial neural mediators (ANMs)
01/17/2008US20080014176 Method of inducing tolerance to betaap 1-42 and myelin basic protein
01/17/2008US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte
01/17/2008US20080014143 Methods and compositions for targeting gC1qR/p32
01/17/2008US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib)
01/17/2008DE19907485B4 Virus-Vakzine Virus vaccine
01/17/2008CA2659673A1 De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
01/17/2008CA2658266A1 Non-replicating paramyxoviridae virus vector
01/17/2008CA2657621A1 Methods and compositions for detecting rare cells from a biological sample
01/17/2008CA2657539A1 Cell growth medium
01/17/2008CA2657310A1 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
01/17/2008CA2657308A1 Treatment of excessive neovascularization
01/17/2008CA2657248A1 Production of glycoproteins
01/17/2008CA2657065A1 A novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells
01/17/2008CA2657040A1 Improved process for the culturing of cells
01/17/2008CA2656786A1 Fatty acid desaturases and uses thereof
01/16/2008EP1878790A1 Epiderm equivalent, capable of pigmenting, obtained from matrix cells, method of preparation and use
01/16/2008EP1878789A1 Fat-derived progenitor cell and use thereof
01/16/2008EP1878744A1 Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
01/16/2008EP1878742A2 HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV
01/16/2008EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b